Overall, our analyses of pan-cancer LGR5 transcript levels is consistent with a previous study ranking colon and rectum, endometrial carcinoma and ovarian cancers as amongst the highest LGR5 expressors relative to other cancers and to their tissues of origin (Junttila et al, 2015). This evidence concerns the gene LGR5 and endometrial carcinoma.